Your browser doesn't support javascript.
loading
Evaluation of 3 Months of Once-Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection.
Walker, Ramara E; Bass, Stephanie; Srinivas, Pavithra; Miranda, Cyndee; Johnson, Lucileia; Pallotta, Andrea M.
Affiliation
  • Walker RE; Cleveland Clinic, OH, USA.
  • Bass S; Cleveland Clinic, OH, USA.
  • Srinivas P; Cleveland Clinic, OH, USA.
  • Miranda C; Cleveland Clinic, OH, USA.
  • Johnson L; Cleveland Clinic, OH, USA.
  • Pallotta AM; Cleveland Clinic, OH, USA.
Ann Pharmacother ; 54(5): 457-463, 2020 05.
Article in En | MEDLINE | ID: mdl-31729245
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Drug-Related Side Effects and Adverse Reactions / Latent Tuberculosis / Isoniazid / Antitubercular Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Drug-Related Side Effects and Adverse Reactions / Latent Tuberculosis / Isoniazid / Antitubercular Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States